Abbvie Inc (NYSE:ABBV)

107.53
Delayed Data
As of Apr 09
 +1.43 / +1.35%
Today’s Change
78.56
Today|||52-Week Range
113.41
+0.35%
Year-to-Date
ABBV Regular Dividend: ABBV will begin trading ex-dividend on 04/14/21 with a $1.30 dividend payable to shareholders of record as of 04/15/21.
4 Green Flags for AbbVie in 2021
6:30am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: ServiceNow, AbbVie and Apple
Apr 09 / Zacks.com - Paid Partner Content
3 Great Dividend Stocks to Buy Right Now
6:01am / MotleyFool.com - Paid Partner Content
3 Must-Own High-Yield Pharmaceutical Stocks to Add to Your Portfolio
Apr 08 / StockNews.com - Paid Partner Content
Better Value Stock: AbbVie or Viatris?
Apr 10 / MotleyFool.com - Paid Partner Content
Bath Savings Trust Co Buys Equinix Inc, Air Products & Chemicals Inc, Cigna Corp, Sells ...
Apr 08 / GuruFocus News - Paid Partner Content
American National Bank Buys Pfizer Inc, AbbVie Inc, Lowe's Inc, Sells Broadcom Inc, Texas ...
Apr 09 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Dermatitis JAK Inhibitor NDA Review Gets Delayed
Apr 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
Apr 09 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Seeks Skyrizi Approval for Psoriatic Arthritis
Apr 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close106.10
Today’s open106.30
Day’s range106.08 - 107.72
Volume5,977,497
Average volume (3 months)7,371,030
Market cap$189.8B
Data as of 4:00pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)-48.39%
Earnings growth (this year)+17.32%
Earnings growth (next 5 years)+4.45%
Revenue growth (last year)+37.69%
P/E ratio39.5
Price/Sales3.91
Price/Book14.52

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.85+1.13%
NVSNovartis+0.56+0.64%
LLYEli Lilly and Co+1.86+1.02%
PFEPfizer+0.64+1.78%
Data as of 5:29pm ET, 04/09/2021

Financials

Next reporting dateApril 30, 2021
EPS forecast (this quarter)$2.81
Annual revenue (last year)$45.8B
Annual profit (last year)$4.6B
Net profit margin9.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts